11 min listen
State of play of the top vaccines
From1 big thing
ratings:
Length:
11 minutes
Released:
Nov 30, 2020
Format:
Podcast episode
Description
There are at least three promising vaccine candidates. Two are likely to get emergency use authorization in the coming weeks. A third showed promising results, but is facing questions. And more candidates are close behind. We walk you through what you need to know.
Plus, how news outlets are adjusting to a time after President Donald Trump.
And, a primer on the social media site Parler.
Guests: Axios' Sam Baker, Sara Fischer, and Dan Primack
Credits: "Axios Today" is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Carol Wu, Cara Shillenn, Nuria Marquez Martinez, Dan Bobkoff, Sara Kehaulani Goo, Alex Sugiura and Naomi Shavin. Music is composed by Evan Viola. You can reach us at podcasts@axios.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Plus, how news outlets are adjusting to a time after President Donald Trump.
And, a primer on the social media site Parler.
Guests: Axios' Sam Baker, Sara Fischer, and Dan Primack
Credits: "Axios Today" is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Carol Wu, Cara Shillenn, Nuria Marquez Martinez, Dan Bobkoff, Sara Kehaulani Goo, Alex Sugiura and Naomi Shavin. Music is composed by Evan Viola. You can reach us at podcasts@axios.com.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Released:
Nov 30, 2020
Format:
Podcast episode
Titles in the series (100)
The end of cash by 1 big thing